Drug Safety
The management of rheumatoid arthritis patients with a history of cancer continues to be an area of concern for rheumatologists. General recommendations are to treat patients with a history of solid…
Adult Still's Disease is labeled as a rare disease as the prevalence of the disease is low – in some reports it is as low as 0.16 per 100,000 population. Adult Still’s disease constitutes Adult…
The patient advocacy organization CreakyJoints will present 13 scientific posters at this year's ACR Convergence 2022 and 8 posters as part of the patient perspectives track. Below is a sampling of…
2 years ago
Did You Know? FDA relaxed warnings on #sarcoma with #Forteo- can use more than 2 years @RheumNow #acr22 #acrreview #osteoporosis https://t.co/Xzr6TZIlWN
2 years ago
Drug holidays for #osteoporosis RX but be note fracture risk may increase with these holidays- consider an anabolic agent during these times - Dr Tanner #acr22 @RheumNow #acrreview https://t.co/6XbpYD5D1X
2 years ago
Dr Tanner presents the features of AFF👇
It is rare, subtrochanteric in location and often appears w/n 5-10 yrs of BP use.
#ACR22 @RheumNow #acrreview #osteoporosis https://t.co/KbMJ4dXfpj
2 years ago
Withdrawing IL17i will more likely cause a relapse, but pts will respond when reintroduced -Dr Scher #PsA @rheumnow #acr22 #acrreview https://t.co/FvWVuQGJda
Rheumatoid arthritis treatment has come leaps and bounds in recent decades. Gone are the days of gold injections, chemical synovectomies, and physician-mandated bedrest (heaven forbid). Though the…
The updated 2022 EULAR recommendations for the management of rheumatoid arthritis (RA) were initially presented by Dr. Josef Smolen at EULAR 2022, and are now in press delineating the most recent…
Poster Hall